| Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study M Maerevoet, JM Zijlstra, G Follows, RO Casasnovas, JSP Vermaat, ... Journal of Hematology & Oncology 14, 1-4, 2021 | 13 | 2021 |
| Impact of the COVID-19 pandemic on the frequency, clinical spectrum and outcomes of pediatric Guillain-Barré syndrome in India: a multicentric ambispective cohort study D Garg, RK Dhamija, A Choudhary, R Shree, S Kumar, P Samal, A Pathak, ... Annals of Indian Academy of Neurology 25 (1), 60-67, 2022 | 8 | 2022 |
| Comparison of the effectiveness and safety of the oral selective inhibitor of nuclear export, selinexor, in diffuse large B cell lymphoma subtypes RO Casasnovas, G Follows, JM Zijlstra, JSP Vermaat, N Kalakonda, ... Clinical Lymphoma Myeloma and Leukemia 22 (1), 24-33, 2022 | 7 | 2022 |
| Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma J Shah, S Shacham, M Kauffman, P Daniele, D Tomaras, G Tremblay, ... Future oncology 17 (11), 1295-1310, 2021 | 7 | 2021 |
| Multiplexing 8 colors with 12 antibodies in a single lymphoid screening tube by flow cytometry for evaluating suspected chronic lymphoproliferative disorders (CLPD) RK Bhola, PK Das, S Pradhan, K Chakraborty, D Mohapatra, P Samal, ... Journal of Hematopathology 13, 13-24, 2020 | 6 | 2020 |
| FISH Analysis in Multiple Myeloma-a Retrospective Study from India P Dhiman, S Goel, P Samal, N Sood, R Sachdev, SP Yadav, AK Vaid Blood 128 (22), 5646, 2016 | 6 | 2016 |
| The association between patient characteristics and the efficacy and safety of selinexor in diffuse large B-cell lymphoma in the SADAL study JM Zijlstra, G Follows, RO Casasnovas, JSP Vermaat, N Kalakonda, ... Cancers 14 (3), 791, 2022 | 5 | 2022 |
| A prospective, randomized study to compare the combination of imatinib and cytarabine versus imatinib alone in newly diagnosed patients with chronic phase chronic myeloid leukemia P Samal, P Chakrabarti, UK Nath Indian Journal of Cancer 56 (3), 211-215, 2019 | 5 | 2019 |
| SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms S Saha, P Samal, S Madhulika, KC Murmu, S Chakraborty, J Basu, ... Blood Advances 6 (10), 3106-3113, 2022 | 4 | 2022 |
| Disseminated BCG-osis with haemophagocytosis, tubercular bacteraemia, and unusual haematological findings with its haematology analyser-based expression RK Bhola, R Sarangi, P Dey, P Samal Journal of Hematopathology 11 (3), 87-92, 2018 | 4 | 2018 |
| Incidental detection of a rare hemoglobin variant (hemoglobin N Seattle) leading to undetectable levels of HbA1c in a diabetic female: a case report S Pradhan, S Chauhan, P Samal Thalassemia Reports 7 (1), 5860, 2017 | 4 | 2017 |
| A fulminant case of Epstein-Barr Virus encephalitis with multiorgan dysfunction S Patnaik, P Samal, A Sahoo, B Mohanty, J Turuk Journal of NeuroVirology 28 (3), 464-466, 2022 | 3 | 2022 |
| Morpheaform leukemia cutis in a case of b-cell acute lymphoblastic leukemia-A rare presentation L Mohapatra, A Ray, PC Patra, P Samal, A Samal, BR Kar Indian Journal of Paediatric Dermatology 23 (1), 74-76, 2022 | 3 | 2022 |
| Serum lipid profiles of patients having beta-thalassemia in a tertiary care hospital P Samal, JN Mohanty, SR Das, SP Routray Annals of the Romanian Society for Cell Biology, 14250-14257, 2021 | 3 | 2021 |
| Molecular and epigenetic alterations in normal and malignant myelopoiesis in human leukemia 60 (HL60) promyelocytic cell line model J Basu, S Madhulika, KC Murmu, S Mohanty, P Samal, A Das, ... Frontiers in Cell and Developmental Biology 11, 1060537, 2023 | 2 | 2023 |
| Drug loaded nanomaterials for hematological malignancies diagnosis and enhanced targeted therapy P Samal, S Begum Advanced Nanomaterials for Point of Care Diagnosis and Therapy, 383-398, 2022 | 2 | 2022 |
| Amyloidosis: the newer discovered ALECT2 associated with der7q add (7) AA ChAkrAbArti, PAA SAmAl, JP ChAkrAbArtty Journal of Clinical and Diagnostic Research: JCDR 10 (9), ED04, 2016 | 2 | 2016 |
| Unveiling the antibacterial and antifungal potential of biosynthesized silver nanoparticles from Chromolaena odorata leaves AK Bishoyi, CR Sahoo, P Samal, NP Mishra, BR Jali, MS Khan, RN Padhy Scientific Reports 14 (1), 7513, 2024 | 1 | 2024 |
| Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India A Patel, N Bhatt, SS Prakash, G Biswas, R Nagarkar, B Roy, P Samal, ... Cancer Chemotherapy and Pharmacology 91 (6), 457-468, 2023 | 1 | 2023 |
| Impact of COVID-19 on Guillain-Barre syndrome in India: A multicenter ambispective cohort study Y Sireesha, R Shree, M Nagappa, A Patil, M Singla, MVP Srivastava, ... Annals of Indian Academy of Neurology 25 (6), 1116-1121, 2022 | 1 | 2022 |
Sarita PradhanAssociate Professor, pathology在 soauniversity.ac.in 的电子邮件经过验证
Sarita PradhanAssociate Professor, pathology在 soauniversity.ac.in 的电子邮件经过验证